Filing Flows › Comparisons › CLPT vs TLSI
ClearPoint Neuro vs TriSalus Life Sciences: CLPT and TLSI compared
ClearPoint Neuro is the larger company: $12.1M of revenue in its latest quarter (Q3 2026) against $11.4M for TriSalus Life Sciences (Q2 2026). ClearPoint Neuro is growing faster (+36% against +2% a year earlier). ClearPoint Neuro is more profitable, with an operating margin of -52.4% against -86.0%.
Where the money goes: CLPT and TLSI
ClearPoint Neuro (CLPT) · Q3 2026
ClearPoint Neuro, Q3 2026: revenue $12.1M (+36% year over year), operating margin -52.4%, net loss $7.5M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
TriSalus Life Sciences (TLSI) · Q2 2026
TriSalus Life Sciences, Q2 2026: revenue $11.4M (+2% year over year), operating margin -86.0%, net loss $9.2M, operating cash flow −$10.1M. The chart follows the revenue to costs, profit and cash.
| ClearPoint Neuro (CLPT) | TriSalus Life Sciences (TLSI) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $12.1M | $11.4M |
| Revenue growth, Y/Y | +36% | +2% |
| Operating margin | -52.4% | -86.0% |
| Net earnings | −$7.5M | −$9.2M |
| Net margin | -61.8% | -80.5% |
| Operating cash flow | −$5.1M | −$10.1M |
Where the revenue comes from
ClearPoint Neuro
- Product: $7.9M (65%)
- Capital Equipment and Software: $1.7M (14%)
- Capital Equipment and Software Systems and Software Products: $1.3M (11%)
- Biologics and Drug Delivery Disposable Products: $1.2M (10%)
Questions
Which is bigger, ClearPoint Neuro or TriSalus Life Sciences?
ClearPoint Neuro is the larger company: $12.1M of revenue in its latest quarter (Q3 2026) against $11.4M for TriSalus Life Sciences (Q2 2026).
Is ClearPoint Neuro or TriSalus Life Sciences growing faster?
ClearPoint Neuro is growing faster (+36% against +2% a year earlier).
Which is more profitable, ClearPoint Neuro or TriSalus Life Sciences?
ClearPoint Neuro is more profitable, with an operating margin of -52.4% against -86.0%.
More: ClearPoint Neuro earnings · how ClearPoint Neuro makes money · TriSalus Life Sciences earnings · how TriSalus Life Sciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Aug 6, 2026). Fiscal quarters can end on different dates. Not investment advice.